BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Early pregnancy factor
,
Trichostatin A
,
rs3825942
,
NEUROG3
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
HMGB1, protein
Summary
General Info
Curated Studies
Most Correlated Studies
Dermal fibroblasts responses to different treatments
HeLa cells with shRNA knockdown of Hmgb1
Embryonic fibroblasts cycling or G1, S-phase synchronized from Hmgb1 knockout mice
NHP6A and NHP6B double knockout S. cerevisiae gene expression
Embryonic kidney 293 with conditional AIRE expression and etoposide treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
The Role of HMGB1 in Rheumatic Diseases.
Interaction of bioactive kaempferol with HMGB1: Investigation by multi-spectroscopic and molecular s…
Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy.
L-ascorbic acid could ameliorate the damage of myocardial microvascular endothelial cell caused by h…
Progress in Assays of HMGB1 Levels in Human Plasma-The Potential Prognostic Value in COVID-19.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood…
HMGB1 Release From Hemorrhagic Shock Patients
Clinical Implications of HMGB1 in Patients Treated With Chemotherapy or Hematopoietic Stem Cell Tran…
Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ